Therapeutic nanoconjugates and uses thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- 巴塞罗那自治大学UAB
- Publication Date
- 2021-11-02
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The present invention relates to the field of nanostructured protein materials, and more particularly relates to fusion proteins carrying therapeutic agents that can be used for treatment. Background technique
[0002] Systemic administration of drugs in the form of nanoconjugates benefits from enhanced drug stability when compared to free molecules. Valuable additional properties such as cell targeting can also be incorporated into a given hybrid composite by chemically incorporating functional groups in the nanoscale carrier, thereby benefiting from the high surface area / volume ratio of nanomaterials . When administered systemically, the resulting drug-loaded conjugates with sizes between about 8 and 100 nm escape renal filtration without aggregation in the lung or other highly vascularized organs. This fact, combined with appropriate physicochemical properties of the material, may lead to prolonged circulation times and drug exposure to target org...